Quantcast

Latest Antiretroviral drug Stories

2014-07-25 09:45:29

University of Cincinnati Academic Health Center Treatment of HIV patients co-infected with the hepatitis C virus (HCV) with an anti-retroviral drug therapy not only tackles HIV, but also reduces HCV replication, according to a new study lead by a University of Cincinnati researcher. The results were published Wednesday, July 23, 2014, in Science Translational Medicine. Previously, physicians treating co-infected patients worried that HIV antiretroviral therapy might injure the liver...

2014-07-24 10:43:07

Temple University Health System Their approach promises a permanent cure and potential for protection against HIV The HIV-1 virus has proved to be tenacious, inserting its genome permanently into its victims' DNA, forcing patients to take a lifelong drug regimen to control the virus and prevent a fresh attack. Now, a team of Temple University School of Medicine researchers has designed a way to snip out the integrated HIV-1 genes for good. "This is one important step on the path...

2014-07-24 00:21:34

MELBOURNE, Australia, July 24, 2014 /PRNewswire/ -- Announced at the 20th International AIDS Conference in Melbourne, the agreement seeks to increase access to a promising new HIV medicine in 112 developing countries At the AIDS 2014 conference in Melbourne today, the Medicines Patent Pool (MPP) announced a new licensing agreement with Gilead Sciences for tenofovir alafenamide (TAF), a promising new medicine currently...

2014-07-22 04:21:22

- iPrEx OLE is the first PrEP demonstration project to report on its experience; results presented as a late-breaker at AIDS 2014, published in Lancet Infectious Diseases - MELBOURNE, Australia, July 22, 2014 /PRNewswire-USNewswire/ -- Oral HIV pre-exposure prophylaxis (PrEP) provides a high degree of protection against HIV infection, even for individuals who miss some daily doses, according to new data from iPrEx OLE, the first PrEP demonstration project to report outcomes. PrEP was...

2014-07-21 11:19:15

The JAMA Network Journals Among heterosexual African couples in which the male was HIV positive and the female was not, receipt of antiretroviral pre-exposure preventive (PrEP) therapy did not result in significant differences in pregnancy incidence, birth outcomes, and infant growth compared to females who received placebo, according to a study in the July 23/30 issue of JAMA, a theme issue on HIV/AIDS. The authors note that these findings do not provide a definitive conclusion regarding...

2014-07-21 11:08:54

The JAMA Network Journals Among adults in the African country of Malawi offered HIV self-testing, optional home initiation of care compared with standard HIV care resulted in a significant increase in the proportion of adults initiating antiretroviral therapy, according to a study in the July 23/30 issue of JAMA, a theme issue on HIV/AIDS. The issue is being released early to coincide with the International AIDS Conference. In 2012, an estimated 35 million individuals were infected...

2014-07-21 10:56:40

Emory Health Sciences In an innovative approach to HIV prevention, an interdisciplinary group of experts has come together for the first time to lay out a framework of best practices to optimize the role of the clinician in achieving an AIDS-free generation. The guidelines, which will be published online in the Journal of the American Medical Association (JAMA), integrate both cutting-edge biomedical advances and evidence-based behavioral interventions for the care of people living with...

2014-07-14 08:27:10

Results Published Ahead of Print in the Journal of Acquired Immune Deficiency Syndromes (JAIDS) WALTHAM, Mass., July 14, 2014 /PRNewswire/ -- Alere Inc. (NYSE: ALR) today announced the publication of a study demonstrating the viability of accurate and rapid HIV screening among infants at the point of care (POC). The study was conducted in five clinics in Maputo, Mozambique, with the prototype of Alere's new POC nucleic acid test, the Alere(TM) q HIV-1/2 Detect assay. Results of the...

2014-07-11 10:26:38

Emory Health Sciences Viral fitness tracks with likelihood of transmission New research on HIV transmission shows that viral fitness is an important basis of a "genetic bottleneck" imposed every time a new person is infected. The findings define a window of opportunity for drugs or vaccines to prevent or limit infection. HIV represents evolution on overdrive. Every infected individual contains a swarm of viruses that exhibit variability in their RNA sequence, and new mutations are...

Child Believed To Be Cured Of HIV Now Has Detectable Virus Levels
2014-07-11 07:38:26

redOrbit Staff & Wire Reports - Your Universe Online The Mississippi infant believed to have been cured of HIV following an extended remission now once again has “detectable levels” of the AIDS-causing virus in her blood, the US National Institute of Allergy and Infectious Diseases (NIAID) has confirmed. The child was born prematurely in 2010 to an HIV-infected mother who had not been diagnosed until the time of delivery and had not been given antiretroviral medication during...


Latest Antiretroviral drug Reference Libraries

0_a4499f7c8759b5cbe79bad5eca319070
2011-01-26 14:08:59

Human immunodeficiency virus (HIV), a lentivirus, causes acquired immunodeficiency syndrome (AIDS) which is a condition in humans were the immune system begins to fail, leading to life-threatening opportunistic infections. Infection is transferred through bodily fluids where HIV is present as both free virus particles and within infected immune cells. The four most common routes of infection are unsafe sex, contaminated needles, breast milk, and transmission from an infected mother to her...

More Articles (1 articles) »
Word of the Day
siliqua
  • A Roman unit of weight, 1⁄1728 of a pound.
  • A weight of four grains used in weighing gold and precious stones; a carat.
  • In anatomy, a formation suggesting a husk or pod.
  • The lowest unit in the Roman coinage, the twenty-fourth part of a solidus.
  • A coin of base silver of the Gothic and Lombard kings of Italy.
'Siliqua' comes from a Latin word meaning 'a pod.'
Related